ALT

1.3305.67%
KO

Klaus O. Schafer

Independent Director

Dr. Brigadier General (ret.), Klaus O. Schafer, M.D., M.S., MPH, serves as the Chief Executive Officer and President of Touchstone Associates LLC. Dr. Schafer is the Founding Partner of Tessarae, Inc. Dr. Schafer co-founded TessArae, LLC. He served as the President of TessArae, LLC until June 2011 and served as its Chief Executive Officer. He served as Technology Advisor of Compressus Inc. He has several years of leadership experience and held senior positions in government and industry. His experiences include senior level strategy and programmatic management of DoD’s 1 billion annual chemical and biological defense program. From 2002 to 2004, he served as Senior Vice President for Business Development for Compressus Inc. He provided consultation to the Defense Threat Reduction Agency at the Department of Defense. From 2004 to 2005, he served as Deputy Assistant to the Secretary of Defense for Chemical and Biological Defense Program, within the Office of the Secretary of Defense (OSD) since 2004. Dr. Schafer oversaw the 2.1 billion annual science, technology, research, development and acquisition program in the area of medical and non-medical materials for chemical biological defense for the entire U.S. Department of Defense. He served as Career Officer in the United States Air Force Medical Service (USAF), where he rank of brigadier general in the position of Air Force Assistant Surgeon General for readiness, science and technology, where he was widely recognized for leadership in the fields of electronic medical records, telemedicine, medical information technology, diagnostic biotechnology and health surveillance. Dr. Schafer worked closely with Congress, international partners and other federal agencies in this key position. He was an Independent Director of Altimmune, Inc. (formerly, Vaxin Inc.) since July 2012 and serves as its an Independent Director since May 2017 (upon completion of the merger with PharmAthene, Inc). Dr. Schafer served as a Member of Scientific Advisory Committee of Avi Biopharma Inc. He is a Graduate of the U.S. Air Force Academy in Colorado Springs, Colo. Dr. Schafer has been an independent consultant since 2002 serving a number of biotech and health-related company advisory boards and Tadpole Ventures, a private venture capital firm. He held the position of Chief Medical Officer and client executive for health at CACI International, an information technology company. He has Doctor of Medicine and Surgery from the University of Iowa Medical School in 1977 and a Master of Public Health degree at the University of Texas Health Center at San Antonio in 1984 and Master of Science at the Dwight D. Eisenhower School of National Security and Resource Strategy. He is certified in cybersecurity oversight from the Carnegie Mellon University Software Engineering Institute.

Positions